Cardiovascular disease in type 2 diabetes mellitus : progress toward personalized management
Ma, Cheng-Xu (The First Clinical Medical College of Lanzhou University)
Ma, Xiao-Ni (The First Clinical Medical College of Lanzhou University)
Guan, Cong-Hui (The First Clinical Medical College of Lanzhou University)
Li, Ying-Dong (College of Integrated Traditional Chinese and Western Medicine. Gansu University of Chinese Medicine)
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau)
Fu, Song-Bo (The First Clinical Medical College of Lanzhou University)
Universitat Autònoma de Barcelona

Date:	2022
Abstract:	Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low- and middle-income countries. To effectively prevent the development of CVDs in T2DM, considerable effort has been made to explore novel preventive approaches, individualized glycemic control and cardiovascular risk management (strict blood pressure and lipid control), together with recently developed glucose-lowering agents and lipid-lowering drugs. This review mainly addresses the important issues affecting the choice of antidiabetic agents and lipid, blood pressure and antiplatelet treatments considering the cardiovascular status of the patient. Finally, we also discuss the changes in therapy principles underlying CVDs in T2DM.
Note:	Altres ajuts: Hospital Fund of the First Hospital of Lanzhou University (ldyyyn2020-93); Construction Program of Gansu Provincial Clinical Medical Research Center for Endocrine Diseases (20JR10FA667); Gansu Provincial Natural Science Foundation (20JR10RA681); Science and Technology Development of the Chinese Central Government to Guide Local in 2020 (1004TCYA032).
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article de revisió ; recerca ; Versió publicada
Subject:	Type 2 diabetes mellitus ; Cardiovascular diseases ; Hyperlipidemia ; Hypertension ; Therapy principle ; Antidiabetic therapy
Published in:	Cardiovascular diabetology, Vol. 21 Núm. 1 (december 2022) , p. 74, ISSN 1475-2840

DOI: 10.1186/s12933-022-01516-6
PMID: 35568946

15 p, 867.3 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles